Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tuberculosis (TB) Aftermath: a Hybrid Type I Effectiveness-implementation Non-inferiority Randomized Trial in India Comparing Two Active Case Finding (ACF) Strategies Among Individuals Treated for TB and Their Household Contacts

NCT04333485 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04333485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tuberculosis (TB) Aftermath: a Hybrid Type I Effectiveness-implementation Non-inferiority Randomized Trial in India Comparing Two Active Case Finding (ACF) Strategies Among Individuals Treated for TB and Their Household Contacts
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2021
Completion date
June 1, 2025
Enrollment
3,094 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis (tb)